pharma | Khurana and Khurana

Liabilities of an Infringer in an Infringement Suit: A Case Analysis

17th December, 2021 - 11:07 am Categories: Intellectual Property

Introduction: In the recent judgment of the Delhi High Court dated 13th December 2021, it was observed that “When an infringer seeks to defend patent infringement on the ground that the patent is invalid, the onus to prove the invalidity of patent lies heavily on an infringer and this standard has to be met when … Continue reading Liabilities of an Infringer in an Infringement Suit: A Case Analysis

Double Patenting and Where it Stands as per Delhi High Court

15th July, 2021 - 5:12 am Categories: Legal Issues

0 Comments

In a recent Judgement by Delhi High Court on 02.11.2020 (CS (Comm) 410/2020 AstraZeneca Ab & Anr v Alkem Laboratories), AstraZeneca (Plaintiff), a reputed British-Swedish multinational Pharmacy & Biotechnology company, was denied an Application under Order 39 Rule 1 &2 under the CPC for grant of Temporary Injunction against Alkem Laboratories (Defendants). It was contended … Continue reading Double Patenting and Where it Stands as per Delhi High Court

Anti Cancer drug: Making it Patient-driven, not Disease-driven

11th April, 2011 - 10:16 am Categories: Patent Commercialisation Pharma- biotech- Patent Commercialisation

0 Comments

Introduction: French compatriots Ipsen and bioMérieux, have been few most potential companies, since 2007 in the development of companion assay to assess patient benefit from a compound useful for treating several severe forms of cancers.Partnership between two companies has focused on the two main broad areas of pharma research: Personalized medicine and Theronostics. Personalized medicine … Continue reading Anti Cancer drug: Making it Patient-driven, not Disease-driven

Roche’s Struggle Over its Patents in India – Two suits, Two oppositions

27th July, 2010 - 4:47 am Categories: Patent Litigation Pharma/Biotech Patent Litigations

2 Comments

The struggle between innovator pharmaceutical companies (mostly in the Western world) and developing world Generic companies has been lately played out in India and especially for the last 2-3 years in the form of litigations and oppositions. Here I would be discussing the specific case of Roche (a Swiss Pharma Company) showcasing its journey of … Continue reading Roche’s Struggle Over its Patents in India – Two suits, Two oppositions

Tag: pharma

Liabilities of an Infringer in an Infringement Suit: A Case Analysis

Double Patenting and Where it Stands as per Delhi High Court

Anti Cancer drug: Making it Patient-driven, not Disease-driven

Roche’s Struggle Over its Patents in India – Two suits, Two oppositions

Categories

Archives